It was also observed that PRL/PRLR could reduce stearoyl–coenzyme A desaturase 1 (SCD1) expression in various hepatic cell lines and animal models, which is the rate-limiting enzyme in monounsaturated fatty acid biosynthesis, thereby leading to the amelioration of hepatic steatosis [28]. The gene discussed is PRLR; the disease is fatty liver disease.